Product Browser

Last updated: 2016/12/4

Product Compare

Product Compare Cancel Click this icon to add products to compare list. Select up to 10 products.

Quick Order (Tutorial)

Input Catalog #,
place order here!
Catalog # :
  • Where to buy
  • Choose your location

LANGERIN 293T Cell Transient Overexpression Lysate(Denatured)

  • Catalog # : H00050489-T01
  • Visit Frequency :
  • Countries :
  • Specification
  • Transfected Cell Line:
  • 293T
  • Plasmid:
  • pCMV-LANGERIN full-length
  • Host:
  • Human
  • Theoretical MW (kDa):
  • 36.19
  • Quality Control Testing:
  • Transient overexpression cell lysate was tested with Anti-LANGERIN antibody (H00050489-B01) by Western Blots.
    SDS-PAGE Gel
    QC Testing of H00050489-T01
    CD207 transfected lysate.
    Western Blot
    QC Testing of H00050489-T01
    Lane 1: CD207 transfected lysate ( 36.19 KDa)
    Lane 2: Non-transfected lysate.
  • Storage Buffer:
  • 1X Sample Buffer (50 mM Tris-HCl, 2% SDS, 10% glycerol, 300 mM 2-mercaptoethanol, 0.01% Bromophenol blue)
  • Storage Instruction:
  • Store at -80°C. Aliquot to avoid repeated freezing and thawing.
  • Applications
  • Western Blot
  • Application Image
  • Western Blot
  • Gene Information
  • Gene Name:
  • CD207
  • Gene Alias:
  • CLEC4K
  • Gene Description:
  • CD207 molecule, langerin
  • Gene Summary:
  • The protein encoded by this gene is expressed only in Langerhans cells which are immature dendritic cells of the epidermis and mucosa. It is localized in the Birbeck granules, organelles present in the cytoplasm of Langerhans cells and consisting of superimposed and zippered membranes. It is a C-type lectin with mannose binding specificity, and it has been proposed that mannose binding by this protein leads to internalization of antigen into Birbeck granules and providing access to a nonclassical antigen-processing pathway. [provided by RefSeq
  • Other Designations:
  • C-type lectin domain family 4, member K,CD207 antigen, langerin,Langerhans cell specific c-type lectin
  • RSS
  • YouTube
  • Linkedin
  • Facebook